Doudou Huang
Nanjing, 210023, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Treatment of COVID-19 by monoclonal antibodies and the traditional Chinese medicine.
Journal: Medicine in novel technology and devices
Published: June 08, 2022
The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis.
Journal: Frontiers in public health
Published: May 10, 2022
PIK3CA mutations contribute to fulvestrant resistance in ER-positive breast cancer.
Journal: American journal of translational research
Published: June 04, 2019
Androgen blockade based clinical trials landscape in triple negative breast cancer.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: April 16, 2018
Emerging therapeutic modalities of PARP inhibitors in breast cancer.
Journal: Cancer treatment reviews
Published: January 07, 2018
PAI-1 induces Src inhibitor resistance via CCL5 in HER2-positive breast cancer cells.
Journal: Cancer science
Published: December 16, 2017
Potential biomarkers of CDK4/6 inhibitors in hormone receptor-positive advanced breast cancer.
Journal: Breast cancer research and treatment
Published: September 07, 2017
An androgen receptor negatively induced long non-coding RNA ARNILA binding to miR-204 promotes the invasion and metastasis of triple-negative breast cancer.
Journal: Cell death and differentiation
Published: August 24, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026